Author

T. Inaba

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:human· 3 Research Focus:cancer & tumor microenvironment· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. Kanai· 2 shared A. Yokoyama· 2 shared H. Matsui· 2 shared H. Okuda· 2 shared R. Miyamoto· 2 shared S. Takahashi· 2 shared A. Hoshino· 1 shared A. Takaori-Kondo· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Kanai

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Engineered ACE2 counteracts vaccine-evading SARS-CoV-2 Omicron variant

N. Ikemura, S. Taminishi, T. Inaba, T. Arimori, D. Motooka, K. Katoh, Y. Kirita, Y. Kirita, S. Li, T. Suzuki, Y. Itoh, Y. Ozaki, S. Nakamura, S. Matoba, D. M. Standley, , A. Hoshino

This paper shows engineered ACE2 neutralizes Omicron and other sarbecoviruses effectively despite its high number of spike mutations.

bioRxiv · Dec 22, 2021 · PreprintMicrobiology

HBO1-MLL interaction promotes AF4/ENL/P-TEFb-mediated leukemogenesis

S. Takahashi, A. Kanai, H. Okuda, R. Miyamoto, T. Kawamura, H. Matsui, T. Inaba, A. Takaori-Kondo, A. Yokoyama

This study identifies the HBO1-MLL interaction as critical for leukemogenesis by facilitating the AF4/ENL/P-TEFb complex-mediated gene activation in MLL fusion proteins.

bioRxiv · Jan 8, 2021Cancer Biology

HOXA9 promotes MYC-mediated leukemogenesis by maintaining gene expression for multiple anti-apoptotic pathways

R. Miyamoto, A. Kanai, H. Okuda, S. Takahashi, H. Matsui, T. Inaba, A. Yokoyama

This study shows HOXA9 promotes MYC-driven leukemogenesis by maintaining anti-apoptotic gene expression through multiple pathways.

bioRxiv · Oct 20, 2020Cancer Biology